These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 2421325)

  • 1. Pre-, per- and post-chemotherapy tumour markers in very advanced testicular cancer.
    Fossa SD; Paus E
    Prog Clin Biol Res; 1985; 203():121. PubMed ID: 2421325
    [No Abstract]   [Full Text] [Related]  

  • 2. Tumour markers in testicular tumours.
    Chisholm GD
    Prog Clin Biol Res; 1985; 203():81-91. PubMed ID: 2421346
    [No Abstract]   [Full Text] [Related]  

  • 3. [Evidence of biochemical markers in a complex diagnostico-therapeutic program in germ cell tumors of the testes].
    Abrahámová J; Motlík K; Malbohan I; Wernischová V
    Cas Lek Cesk; 1983 Jul; 122(26):824-9. PubMed ID: 6193884
    [No Abstract]   [Full Text] [Related]  

  • 4. The case for observation of patients with clinical stage I nonseminomatous germ cell testicular tumors.
    Swanson DA
    Semin Urol; 1993 May; 11(2):92-8. PubMed ID: 7689741
    [No Abstract]   [Full Text] [Related]  

  • 5. Transient rise in tumor marker after initial adjuvant chemotherapy for testicular cancer.
    Wolf DJ; Williams JJ
    Urology; 1982 Jul; 20(1):50-2. PubMed ID: 6180542
    [No Abstract]   [Full Text] [Related]  

  • 6. [Clinical studies of testicular tumor. II. Analysis of 30 patients with nonseminomatous testicular tumor].
    Tsukamoto T; Kumamoto Y; Ohmura K; Tsunekawa T; Yamazaki K
    Hinyokika Kiyo; 1986 Jul; 32(7):999-1011. PubMed ID: 2430437
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A case of advanced testicular seminoma--chemotherapy and serum marker].
    Nakamura K; Hagiwara M; Aikawa A; Deguchi N; Tazaki H; Takeshita E; Ito S
    Gan No Rinsho; 1983 Dec; 29(15):1779-82. PubMed ID: 6199531
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-dose methotrexate, vincristine and cisplatin as salvage treatment for relapsed non-seminomatous germ-cell cancer.
    Sleijfer S; Van der Graaf WT; Willemse PH; De Vries EG; Schraffordt Koops H; Mulder NH
    Anticancer Res; 1995; 15(3):1039-42. PubMed ID: 7544087
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Testis tumor markers: how accurate are they?
    deVere White R; Karian S; Hong WK; Olsson CA
    J Urol; 1981 May; 125(5):661-3. PubMed ID: 6164799
    [No Abstract]   [Full Text] [Related]  

  • 10. Multivariate analysis of prognostic factors in patients with disseminated nonseminomatous testicular cancer: results from a European Organization for Research on Treatment of Cancer Multiinstitutional Phase III Study.
    Stoter G; Sylvester R; Sleijfer DT; ten Bokkel Huinink WW; Kaye SB; Jones WG; van Oosterom AT; Vendrik CP; Spaander P; de Pauw M
    Cancer Res; 1987 May; 47(10):2714-8. PubMed ID: 2436756
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic factors in metastatic nonseminomatous germ cell tumours.
    Hanson PR; Belitsky P; Millard OH; Lannon SG
    Can J Surg; 1993 Dec; 36(6):537-40. PubMed ID: 7504978
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated serum tumor markers in patients with testicular cancer after induction chemotherapy due to a reservoir of markers in cystic differentiated mature teratoma.
    van der Gaast A; Hoekstra JW; Croles JJ; Splinter TA
    J Urol; 1991 Apr; 145(4):829-31. PubMed ID: 1706441
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The predictive value of pre-orchidectomy serum tumor markers in non seminomatous germ cell tumors of the testis (N.S.G.C.T.T.).
    Boccon-Gibod L; Le Doze H; Steg A
    Prog Clin Biol Res; 1985; 203():93-5. PubMed ID: 2421347
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [An unusual seminoma].
    Deminière C; Paradis V; Vieillefond A; Savin de Larclause AM; Morard JL
    Ann Pathol; 1994; 14(2):127-8. PubMed ID: 7515236
    [No Abstract]   [Full Text] [Related]  

  • 15. beta-HCG producing seminoma.
    Fossa SD; Risberg T
    Prog Clin Biol Res; 1985; 203():105-6. PubMed ID: 2421322
    [No Abstract]   [Full Text] [Related]  

  • 16. Serum alpha-fetoprotein and beta-human chorionic gonadotropin levels in patients with non-seminomatous germ cell testicular cancer.
    Lange PH; Hakala TR; Fraley EE
    Minn Med; 1975 Nov; 58(11):813-5. PubMed ID: 53783
    [No Abstract]   [Full Text] [Related]  

  • 17. Non-seminoma stage III. Current possibilities of "salvage" chemotherapy.
    Schmidt CG
    Prog Clin Biol Res; 1984; 153():201-18. PubMed ID: 6206506
    [No Abstract]   [Full Text] [Related]  

  • 18. Tumor markers in urology.
    Grossman HB
    Semin Urol; 1985 Feb; 3(1):10-7. PubMed ID: 2408306
    [No Abstract]   [Full Text] [Related]  

  • 19. Spermatic blood beta HCG levels in testicular tumors and in varicocele.
    Fiet J; Jardin A; Gourmel B; Villette JM; Guechot J; Gueux B
    Prog Clin Biol Res; 1985; 203():117-20. PubMed ID: 2421324
    [No Abstract]   [Full Text] [Related]  

  • 20. [Serum levels of alpha fetoprotein (AFP), B-chorionic gonadotropin (BHCG), ferritin and prostatic acid phosphatase (PAP) in patients with cancer of the stomach].
    Bukowski J; Góźdź S; Słuszniak J; Słuszniak A; Korejba W; Zieliński A; Banasińska E
    Wiad Lek; 1988 Jul; 41(14):915-20. PubMed ID: 2467444
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.